SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001543053-18-000003
Filing Date
2018-01-12
Accepted
2018-01-12 15:13:18
Documents
1
Period of Report
2018-01-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 4217
  Complete submission text file 0001543053-18-000003.txt   5619
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Issuer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 4233 TECHNOLOGY DRIVE DURHAM NC 27704
Business Address
Harrelson Lori R. (Reporting) CIK: 0001543053 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35443 | Film No.: 18525806